The Crazy 'Raid' Of Trump's Former Doctor

Agencies
May 2, 2018

May 2: President Donald Trump has never been a model of medical disclosure. Both of his most recent personal doctors have offered unbelievably rosy reviews of his health, omitting or spinning key facts, and both have had their credibility called into question.

We may be finding out why they did what they did.

NBC News just reported on what might be the craziest White House story you'll read this week. It involves Trump's colorful longtime personal doctor, Harold Bornstein, who claims that Trump's bodyguard, a Trump Organization lawyer and a third man conducted a "raid" of his office in February 2017, seizing 35 years of Trump's medical records. And on top of that, Bornstein now says Trump dictated his own initial doctor's letter, according to CNN.

The biggest question on the former is whether any laws were broken with the seizure, which Bornstein said left him feeling "raped, frightened and sad." Bornstein said he wasn't provided a Health Insurance Portability and Accountability Act (HIPAA) release signed by the patient, Trump, which would be a violation. (An individual told NBC that there was a letter from Trump's then-White House doctor, Ronny L. Jackson, but that it wouldn't be sufficient.)

The second-biggest takeaway here, though, is how heavy-handed all this was. That may speak to why we still don't have a completely sober-minded review of Trump's health.

The event that appeared to set in motion the "raid" was Bornstein's disclosure in a New York Times interview that Trump takes a hair-loss drug, Propecia, along with medication for rosacea. Neither drug was disclosed in Trump's doctor's letters, and Trump failed to correct the record on two occasions. When Dr. Mehmet Oz interviewed him about his health and said the only medication Trump was taking was a statin, Trump mentioned neither of the other drugs. Later, Oz mentioned Trump's low PSA (prostate-specific antigen), which is a side effect of Propecia (or finasteride), which is also used as a prostate drug. But Trump didn't connect those dots. Instead, he said: "My PSA has been very good. I don't know what's going on."

It's extremely logical to assume that Trump was feeling self-conscious about the drugs he took for his hair and skin and decided not to disclose them. In Bornstein's telling, this disclosure seemed to set Trump World off. The day the New York Times interview ran, he said, Trump's longtime personal assistant Rhona Graff called him and told him, "So you wanted to be the White House doctor? Forget it; you're out." Two days later came the "raid."

Bornstein said he didn't realize what all the fuss was about when it came to Trump taking Propecia. "I couldn't believe anybody was making a big deal out of a drug to grow his hair that seemed to be so important," he told NBC News. "And it certainly was not a breach of medical trust to tell somebody they take Propecia to grow their hair. What's the matter with that?"

That's a little Pollyannaish. Everyone has a right to medical privacy, even the president. And regardless of Trump's lack of disclosure, perhaps an angry reaction was to be expected.

But that doesn't necessarily justify the "raid" that ensued. Nor do we know why Trump's aides seized the records rather than filing a complaint against Bornstein. It's not too conspiratorial to say Bornstein was disclosing things that Trump didn't want disclosed, and they sought to stop it - using muscle.

This isn't the first time Bornstein has alleged being pressured by those around Trump. He justified his initial, extremely over-the-top review of Trump's health by saying he was given five minutes to draft it while a limo waited outside his office. He later moderated the things he had said, including that Trump would be the healthiest president ever. Now he is telling CNN that Trump dictated the letter. And the fact that Trump's use of the hair-loss and rosacea drugs was obscured in the first place suggests Bornstein wasn't allowed to be particularly forthcoming.

We've long had reason to believe Trump didn't treat his medical records and status with much thought or care - and perhaps that the doctors treating him had been infected with a kind of "Trumpitis," picking up on the president's own penchant for hyperbole.

This suggests, though, that Trump has taken an acute and controlling interest in what his doctors say (and don't say) about him - so much so that he may be willing to launch a little shock-and-awe operation that might have been illegal.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 28,2020

Washington, Apr 28: After nearly three weeks in an intensive care unit in Los Angeles, doctors treating 41-year-old Broadway actor Nick Cordero for COVID-19 were forced to amputate his right leg.

The flow of blood had been impeded by a blood clot: yet another dangerous complication of the disease that has been bubbling up in frontline reports from China, Europe and the United States.

To be sure, so-called "thrombotic events" occur for a variety of reasons among intensive care patients, but the rates among COVID-19 patients are far higher than would be otherwise expected.

"I have had 40-year-olds in my ICU who have clots in their fingers that look like they'll lose the finger, but there's no other reason to lose the finger than the virus," Shari Brosnahan, a critical care doctor at NYU Langone said.

One of these patients is suffering from a lack of blood flow to both feet and both hands, and she predicts an amputation may be necessary, or the blood vessels may get so damaged that an extremity could drop off by itself.

Blood clots aren't just dangerous for our limbs, but can make their way to the lungs, heart or brain, where they may cause lethal pulmonary embolisms, heart attacks, and strokes.

A recent paper from the Netherlands in the journal Thrombosis Research found that 31 percent of 184 patients suffered thrombotic complications, a figure that the researchers called "remarkably high" -- even if extreme consequences like amputation are rare.

Behnood Bikdeli, a doctor at New York-Presbyterian Hospital, assembled an international consortium of experts to study the issue. Their findings were published in the Journal of The American College of Cardiology.

The experts found the risks were so great that COVID-19 patients "may need to receive blood thinners, preventively, prophylactically," even before imaging tests are ordered, said Bikdeli.

What exactly is causing it? The reasons aren't fully understood, but he offered several possible explanations.

People with severe forms of COVID-19 often have underlying medical conditions like heart or lung disease -- which are themselves linked to higher rates of clotting.

Next, being in intensive care makes a person likelier to develop a clot because they are staying still for so long. That's why for example people are encouraged to stretch and move around on long haul flights.

It's also now clear the COVID-19 illness is associated with an abnormal immune reaction called "cytokine storm" -- and some research has indicated this too is linked to higher rates of clotting.

There could also be something about the virus itself that is causing coagulation, which has some precedent in other viral illnesses.

A paper in the journal The Lancet last week showed that the virus can infect the inner cell layer of organs and of blood vessels, called the endothelium. This, in theory, could interfere with the clotting process.

According to Brosnahan, while thinners like Heparin are effective in some patients, they don't work for all patients because the clots are at times too small.

"There are too many microclots," she said. "We're not sure exactly where they are."

Autopsies have in fact shown some people's lungs filled with hundreds of microclots.

The arrival of a new mystery however helps solve a slightly older one.

Cecilia Mirant-Borde, an intensive care doctor at a military veterans hospital in Manhattan, told AFP that lungs filled with microclots helped explain why ventilators work poorly for patients with low blood oxygen.

Earlier in the pandemic doctors were treating these patients according to protocols developed for acute respiratory distress syndrome, sometimes known as "wet lung."

But in some cases, "it's not because the lungs are occupied with water" -- rather, it's that the microclotting is blocking circulation and blood is leaving the lungs with less oxygen than it should.

It has just been a little under five months since the virus emerged in Wuhan, China, and researchers are learning more about its impact every day.

"While we react surprised, we shouldn't be as surprised as we were. Viruses tend to do weird things," said Brosnahan.

While the dizzying array of complications may seem daunting, "it's possible there'll be one or a couple of unifying mechanisms that describe how this damage happens," she said.

"It's possible it's all the same thing, and that there'll be the same solution."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 17,2020

Paris, Apr 17: The number of coronavirus-related deaths in France has increased by 753 to 17,920 over the past 24 hours, with the total case count now standing at 108,847, Jerome Salomon, the head of the state health agency, said on Thursday.

On Wednesday, the country reported a total of 106,206 cases, including a record 1,438 new fatalities. Salomon specified that it was not the daily death toll, as the data had been compiled over the last three-day weekend.

"The total number of victims since March 1 is 17,920," Salomon said at a briefing on Thursday.
He noted that 11,060 of them had died in hospitals, and 6,860 others in social and medical-social facilities.

President Emmanuel Macron on Monday extended nationwide movement restrictions, which had been introduced due to the epidemic, until May 11. Afterwards, the country is set to gradually reopen kindergartens, schools and universities.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 22,2020

Davos, Jan 22: President Donald Trump has said that the US is watching the developments between India and Pakistan over Kashmir "very closely" and repeated his offer to "help" resolve the longstanding dispute between the two neighbours as he met Prime Minister Imran Khan on the sidelines of the World Economic Forum here in the Swiss ski resort.

Addressing the media with the Pakistan Prime Minister prior to their private meeting on Tuesday, President Trump asserted that trade and borders were both critical points for discussion, while Khan said that for him, Afghanistan was the top priority.

Trump told Khan, whom he referred to as "my friend", that he would speak to Prime Minister Narendra Modi about the ongoing Kashmir issue. The US president is expected to visit India in the coming weeks, marking his first visit after taking up his post in the White House.

"What's going on between Pakistan and India … if we can help, we certainly will be willing to. We have been watching it very closely and it's an honour to be here with my friend," he said.

"The Pakistan-India conflict is a very big issue for us in Pakistan and we expect the US to always play its part in deescalating the tensions, because no other country can," Khan said.

President Trump has repeatedly offered to mediate following India's August 5 decision to revoke the special status to Jammu and Kashmir and bifurcate the state into two Union Territories, evoking strong reaction from Pakistan which has been trying to internationalise the Kashmir issue.

New Delhi has defended the move, saying Jammu and Kashmir is an integral part of India and the issue was strictly internal to the country, and the special status provisions only gave rise to terrorism in Jammu and Kashmir.

"The country took the decision of abrogation of Article 370, which had only given separatism and terrorism to that state," Prime Minister Narendra Modi said at a function in October last year.

This is the third meeting between Trump and Khan since Pakistan premier assumed office in 2018 and it came against the backdrop of Pakistan Foreign Minister Shah Mehmood Qureshi's recent trip to the US, amid reports that the US and Afghan Taliban were close to striking a peace deal.

"There are issues we want to talk about. The main issue is Afghanistan because it concerns the US and Pakistan. Fortunately, we are on the same page. Both of us are interested in peace there and an orderly transition in Afghanistan with talks with Taliban and the government," Khan said.

When a reporter asked Trump if he would visit Pakistan considering he was already set to visit India, the US president said he was meeting the Pakistan premier in Davos.

"Well, we're visiting right now. So we don't really have to. I wanted to say that from a relationship standpoint, we got a great relationship. From the standpoint our two countries, we're getting along very well. I would say we've never been closer with Pakistan the way we're right now. And this is a big statement," Trump said.

Khan left for Switzerland to attend the World Economic Forum and meet the world leaders, including President Trump, on the sidelines of the annual event which kicked off at the ski resort town of Davos on Tuesday.

The four-day summit marks the 50th anniversary of the forum.

A total of 53 heads of State are on the guest list. Nearly 3,000 participants from 118 countries are expected to attend the event during which political leaders, business executives, heads of international organisations and civil society representatives are set to deliberate on contemporary economic, geopolitical, social and environmental issues.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.